This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Loudig, O. Articles by Petkovich, M. Search for Related Content PubMed PubMed Citation Articles by Loudig, O. Articles by Petkovich, M.

Cytochrome P450RAI(CYP26) Promoter: A Distinct Composite Retinoic Acid Response Element Underlies the Complex Regulation of Retinoic Acid Metabolism

Cancer Research Laboratories (O.L., C.B., J.W., S.A.-A., C.M., M.P.) Departments of Biochemistry (O.L., C.M., M.P.) and Pathology (J.W., S.A.-A., C.M., M.P.) Queen’s University Kingston, Ontario, Canada K7L 3N6

The catabolism of retinoic acid (RA) is an essential mechanism for restricting the exposure of specific tissues and cells to RA. We recently reported the identification of a RA-inducible cytochrome P450 [P450RAI(CYP26)], in zebrafish, mouse, and human, which was shown to be responsible for RA catabolism. P450RAI exhibits a complex spatiotemporal pattern of expression during development and is highly inducible by exogenous RA treatment in certain tissues and cell lines. Sequence analysis of the proximal upstream region of the P450RAI promoter revealed a high degree of conservation between zebrafish, mouse, and human. This region of the promoter contains a canonical retinoic acid response element (5'-AGTTCA-(n)₅-AGTTCA-3'), embedded within a 32-bp region (designated R1), which is conserved among all three species. Electrophoretic mobility shift assays using this element demonstrated the specific binding of murine retinoic acid receptor- (RAR) and retinoid X receptor- (RXR) proteins. Transient transfection experiments with the mouse P450RAI promoter fused to a luciferase reporter gene showed transcriptional activation in the presence of RA in HeLa, Cos-1, and F9 wild-type cells. This activation, as well as basal promoter activity, was abolished upon mutation of the RARE. Deletion and mutational analyses of the P450RAI promoter, as well as DNase I footprinting studies, revealed potential binding sites for several other proteins in conserved regions of the promoter. Also, two conserved 5'-TAAT-3' sequences flanking the RARE were investigated for their potential importance in P450RAI promoter activity. Moreover, these studies revealed an essential requirement for a G-rich element (designated GGRE), located just upstream of the RARE, for RA inducibility. This element was demonstrated to form complexes with Sp1 and Sp3 using nuclear extracts from either murine F9 or P19 cells. Together, these results indicate that the P450RAI-RARE is atypical in that conserved flanking sequences may play a very important role in regulating RA inducibility and expression of P450RAI(CYP26).

This article has been cited by other articles:

				X. Ye and R. Lotan Potential misinterpretation of data on differential gene expression in normal and malignant cells in vitro Brief Funct Genomic Proteomic, July 1, 2008; 7(4): 322 - 326. [Abstract] [Full Text] [PDF]

				R. F. Gillespie and L. J. Gudas Retinoic Acid Receptor Isotype Specificity in F9 Teratocarcinoma Stem Cells Results from the Differential Recruitment of Coregulators to Retinoic Acid Response Elements J. Biol. Chem., November 16, 2007; 282(46): 33421 - 33434. [Abstract] [Full Text] [PDF]

				P. Ocaya, A. C. Gidlof, P. S. Olofsson, H. Torma, and A. Sirsjo CYP26 Inhibitor R115866 Increases Retinoid Signaling in Intimal Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., July 1, 2007; 27(7): 1542 - 1548. [Abstract] [Full Text] [PDF]

				R. Quere, A. Baudet, B. Cassinat, G. Bertrand, J. Marti, L. Manchon, D. Piquemal, C. Chomienne, and T. Commes Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity Blood, May 15, 2007; 109(10): 4450 - 4460. [Abstract] [Full Text] [PDF]

				R. Zolfaghari, C. J. Cifelli, S. O. Lieu, Q. Chen, N.-q. Li, and A. C. Ross Lipopolysaccharide opposes the induction of CYP26A1 and CYP26B1 gene expression by retinoic acid in the rat liver in vivo Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G1029 - G1036. [Abstract] [Full Text] [PDF]

				R. E. Hernandez, A. P. Putzke, J. P. Myers, L. Margaretha, and C. B. Moens Cyp26 enzymes generate the retinoic acid response pattern necessary for hindbrain development Development, January 1, 2007; 134(1): 177 - 187. [Abstract] [Full Text] [PDF]

				P. Germain, P. Chambon, G. Eichele, R. M. Evans, M. A. Lazar, M. Leid, A. R. De Lera, R. Lotan, D. J. Mangelsdorf, and H. Gronemeyer International Union of Pharmacology. LX. Retinoic Acid Receptors Pharmacol. Rev., December 1, 2006; 58(4): 712 - 725. [Abstract] [Full Text] [PDF]

				C. Roberts, S. Ivins, A. C. Cook, A. Baldini, and P. J. Scambler Cyp26 genes a1, b1 and c1 are down-regulated in Tbx1 null mice and inhibition of Cyp26 enzyme function produces a phenocopy of DiGeorge Syndrome in the chick Hum. Mol. Genet., December 1, 2006; 15(23): 3394 - 3410. [Abstract] [Full Text] [PDF]

				T. Nagano, S. Takehara, M. Takahashi, S. Aizawa, and A. Yamamoto Shisa2 promotes the maturation of somitic precursors and transition to the segmental fate in Xenopus embryos Development, December 1, 2006; 133(23): 4643 - 4654. [Abstract] [Full Text] [PDF]

				D. N. Shelton, I. T. Sandoval, A. Eisinger, S. Chidester, A. Ratnayake, C. M. Ireland, and D. A. Jones Up-regulation of CYP26A1 in Adenomatous Polyposis Coli-Deficient Vertebrates via a WNT-Dependent Mechanism: Implications for Intestinal Cell Differentiation and Colon Tumor Development. Cancer Res., August 1, 2006; 66(15): 7571 - 7577. [Abstract] [Full Text] [PDF]

				L. M. Hoffman, K. Garcha, K. Karamboulas, M. F. Cowan, L. M. Drysdale, W. A. Horton, and T. M. Underhill BMP action in skeletogenesis involves attenuation of retinoid signaling J. Cell Biol., July 3, 2006; 174(1): 101 - 113. [Abstract] [Full Text] [PDF]

				G. R. Chichili, D. Nohr, M. Schaffer, J. von Lintig, and H. K. Biesalski {beta}-Carotene Conversion into Vitamin A in Human Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3562 - 3569. [Abstract] [Full Text] [PDF]

				S. S. Williams, J. P. Mear, H.-C. Liang, S. S. Potter, B. J. Aronow, and M. C. Colbert Large-scale reprogramming of cranial neural crest gene expression by retinoic acid exposure Physiol Genomics, October 4, 2004; 19(2): 184 - 197. [Abstract] [Full Text] [PDF]

				M. G. Villani, V. Appierto, E. Cavadini, M. Valsecchi, S. Sonnino, R. W. Curley, and F. Formelli Identification of the Fenretinide Metabolite 4-Oxo-Fenretinide Present in Human Plasma and Formed in Human Ovarian Carcinoma Cells through Induction of Cytochrome P450 26A1 Clin. Cancer Res., September 15, 2004; 10(18): 6265 - 6275. [Abstract] [Full Text] [PDF]

				F. Andreola, G. P. Hayhurst, G. Luo, S. S. Ferguson, F. J. Gonzalez, J. A. Goldstein, and L. M. De Luca Mouse Liver CYP2C39 Is a Novel Retinoic Acid 4-Hydroxylase: ITS DOWN-REGULATION OFFERS A MOLECULAR BASIS FOR LIVER RETINOID ACCUMULATION AND FIBROSIS IN ARYL HYDROCARBON RECEPTOR-NULL MICE J. Biol. Chem., January 30, 2004; 279(5): 3434 - 3438. [Abstract] [Full Text] [PDF]

				M. Taimi, C. Helvig, J. Wisniewski, H. Ramshaw, J. White, M.'a. Amad, B. Korczak, and M. Petkovich A Novel Human Cytochrome P450, CYP26C1, Involved in Metabolism of 9-cis and All-trans Isomers of Retinoic Acid J. Biol. Chem., January 2, 2004; 279(1): 77 - 85. [Abstract] [Full Text] [PDF]

				A. C. Ross and R. Zolfaghari Regulation of Hepatic Retinol Metabolism: Perspectives from Studies on Vitamin A Status J. Nutr., January 1, 2004; 134(1): 269S - 275. [Abstract] [Full Text] [PDF]

				P. Costet, F. Lalanne, M. C. Gerbod-Giannone, J. R. Molina, X. Fu, E. G. Lund, L. J. Gudas, and A. R. Tall Retinoic Acid Receptor-Mediated Induction of ABCA1 in Macrophages Mol. Cell. Biol., November 1, 2003; 23(21): 7756 - 7766. [Abstract] [Full Text] [PDF]

				T. Kudoh, S. W. Wilson, and I. B. Dawid Distinct roles for Fgf, Wnt and retinoic acid in posteriorizing the neural ectoderm Development, March 11, 2003; 129(18): 4335 - 4346. [Abstract] [Full Text] [PDF]

				A. B. Goodman and A. B. Pardee Evidence for defective retinoid transport and function in late onset Alzheimer's disease PNAS, March 4, 2003; 100(5): 2901 - 2905. [Abstract] [Full Text] [PDF]

				J. M. Spitsbergen and M. L. Kent The State of the Art of the Zebrafish Model for Toxicology and Toxicologic Pathology Research--Advantages and Current Limitations Toxicol Pathol, January 1, 2003; 31(1_suppl): 62 - 87. [Abstract] [PDF]

				A. C. Ross Retinoid Production and Catabolism: Role of Diet in Regulating Retinol Esterification and Retinoic Acid Oxidation J. Nutr., January 1, 2003; 133(1): 291S - 296. [Abstract] [Full Text] [PDF]

				J. V. Chithalen, L. Luu, M. Petkovich, and G. Jones HPLC-MS/MS analysis of the products generated from all-trans-retinoic acid using recombinant human CYP26A J. Lipid Res., July 1, 2002; 43(7): 1133 - 1142. [Abstract] [Full Text] [PDF]

				I. Klaassen, R. H. Brakenhoff, S. J. Smeets, G. B. Snow, and B. J. M. Braakhuis Enhanced Turnover of all-trans-Retinoic Acid and Increased Formation of Polar Metabolites in Head and Neck Squamous Cell Carcinoma Lines Compared with Normal Oral Keratinocytes Clin. Cancer Res., April 1, 2001; 7(4): 1017 - 1025. [Abstract] [Full Text]